Leaflet NOSTAMINE 0.5mg / 0.5mg / ml eye / nasal drops, solution

Product code: W44055001 Quantity: 1

Indicated for: allergic rhinitis; urticaria

Route of administration: ophthalmic / nasal

Substance: naphazoline + chlorpheniramine maleate (adrenergic decongestant + antiallergic agent)

ATC: S01GA51 (Sensory organs | Decongestants and antiallergics | Sympathomimetics used as decongestants)

Precautions:
Driving impairment
Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo
Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Glaucoma warning
Glaucoma warning

Use caution if you have glaucoma or increased eye pressure.

Anticholinergic effects
Anticholinergic effects

May cause dry mouth, constipation, urinary retention, or blurred vision.

Cardiac risk / QT prolongation / arrhythmias
Cardiac risk / QT prolongation / arrhythmias

This medicine may increase the risk of heart rhythm disturbances.

Drowsiness / sedation
Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

The combination of Naphazoline + Chlorpheniramine Maleate is used for the symptomatic treatment of allergic rhinitis and nasal congestion. It combines the decongestant effect of Naphazoline with the antihistamine properties of chlorpheniramine, providing rapid symptom relief.

The medication is available as nasal drops and is effective in reducing inflammation, congestion, and nasal itching. It is intended for short-term use, typically no more than 5-7 days.

Side effects may include dryness of the nasal mucosa, drowsiness, or local irritation. Prolonged use may lead to rebound congestion or other complications.

Consult your doctor before use, especially if you have chronic conditions or are taking other medications. Follow the recommended dosage to avoid side effects.

General data about NOSTAMINE 0.5mg / 0.5mg / ml

  • Substance: naphazoline + chlorpheniramine maleate
  • Date of latest medicines list: 01-07-2013
  • Product code: W44055001
  • Concentration: 0.5mg / 0.5mg / ml
  • Pharmaceutical form: eye / nasal drops, solution
  • Packing volume: 10 ml
  • Product type: Generic medicine
  • Prescription status: OTC - Over the Counter = medicine that does not require a medical prescription.

Marketing authorisation

  • Manufacturer: FELSIN FARM S.R.L. - ROMANIA
  • Holder: E.I.P.I.C.O MED S.R.L. - ROMANIA
  • Number: 11736/2019/01
  • Shelf life: 3 years-dupa ambalatra pt. comercializare; 28 days-after the first opening of the bottle